Meningitis, Cryptococcal: all 54 studies

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low TitersNot yet recruitingNCT07743593Phase 3
• Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)RecruitingNCT06666322Phase 2/3
• Amphotericin B for Non-HIV Cryptococcal Meningitis PatientsEnrolling by invitationNCT06178627Phase 4
• Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal AntigenemiaRecruitingNCT03945448Phase 2/3
• Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ LymphocytopeniaRecruitingNCT00867269
• Fungal Infection SusceptibilityRecruitingNCT00001352
• Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal MeningitisCompletedNCT06414512Phase 2Results posted
• Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal MeningitisCompletedNCT01802385Phase 3Results posted
• Cryptococcal Optimal ART Timing TrialCompletedNCT01075152Phase 4Results posted
• High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected IndividualsCompletedNCT00885703Phase 1/2Results posted
• Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated MeningitisCompletedNCT00145249Phase 2Results posted
• Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico CityStatus unknownNCT05685641Not applicable
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3Status unknownNCT05541107Phase 3
• Clinical Study of ABCD in the Treatment of Cryptococcal MeningitisStatus unknownNCT05471063Not applicable
• Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal MeningitisCompletedNCT04532463
• The Lived Experience of Participants in an African Randomised TrialCompletedNCT04296292
• AmB Dose for Cryptococcal MeningitisStatus unknownNCT04140461Phase 3
• Three Induction Treatments on Cryptococcal MeningitisStatus unknownNCT04072640Early Phase 1
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)CompletedNCT04031833Phase 1/2
• Vietnam Cryptococcal Retention in Care Study - Version 2.1Status unknownNCT03267407
• Driving Reduced AIDS-associated Meningo-encephalitis MortalityCompletedNCT03226379Not applicable
• Treatment With Tamoxifen in Cryptococcal MeningitisCompletedNCT03112031Phase 2
• Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial ReportCompletedNCT02955862Phase 1
• Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal MeningitisStatus unknownNCT02686853Phase 4
• Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDSStatus unknownNCT02624453Not applicable
• CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan AfricaCompletedNCT02434172
• Vietnam Cryptococcal Retention in Care Study Version 1.0Status unknownNCT02334670
• Liposomal Amphotericin B for the Treatment of Cryptococcal MeningitisStatus unknownNCT02136030Not applicable
• Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral TherapyCompletedNCT02098525
• Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan AfricaStatus unknownNCT01715922Phase 2/3
• Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRCCompletedNCT01589289Phase 3
• Operational Research for Cryptococcal Antigen ScreeningCompletedNCT01535469Phase 4
• Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal MeningitisCompletedNCT00976040Phase 4
• Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedNCT00847678Phase 2
• Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in AfricaCompletedNCT00830856Not applicable
• Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedNCT00324025Phase 2
• Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal MeningitisCompletedNCT00012467Phase 2
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal MeningitisCompletedNCT00002316Phase 1
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin BCompletedNCT00002306Not applicable
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal MeningitisCompletedNCT00002305Not applicable
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDSCompletedNCT00002294Not applicable
• A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.CompletedNCT00002113Not applicable
• An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002077Not applicable
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002076Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002075Not applicable
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00002074Not applicable
• A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002068Not applicable
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002040Not applicable
• Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00002019Not applicable
• Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDSCompletedNCT00001017Phase 3
• Dexamethasone in Cryptococcal MeningitisCompletedNCT00000776Phase 2
• Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00000708Not applicable
• SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance TherapyCompletedNCT00000677Phase 1
• A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00000639Not applicable

← Meningitis, Cryptococcal overview